Secondary Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

Synthetic cannabinoids: A review of the clinical implications of a new drug of choice

Freund, Shaina A. MHS, PA-C; Banning, Adrian S. MMS, PA-C

Journal of the American Academy of PAs: November 2017 - Volume 30 - Issue 11 - p 1–4
doi: 10.1097/01.JAA.0000525914.28344.e2
Review Article
Buy
SDC

ABSTRACT Synthetic marijuana use is an emerging public health problem in the United States, and can cause agitation, severe psychosis, bizarre hallucinations, and possibly death. This article describes these products, which are unregulated and can vary widely in composition, and how clinicians can recognize patients with synthetic cannabinoid toxicity and treat them appropriately to minimize morbidity and mortality.

Shaina A. Freund practices pediatrics at New York-Presbyterian Hospital—Weill Cornell Medical Center in New York City. Adrian S. Banning is an assistant clinical professor in the PA program at Drexel University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Copyright © 2017 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website